256 related articles for article (PubMed ID: 22340325)
21. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.
Bieback K; Hecker A; Kocaömer A; Lannert H; Schallmoser K; Strunk D; Klüter H
Stem Cells; 2009 Sep; 27(9):2331-41. PubMed ID: 19544413
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells.
Pal R; Hanwate M; Jan M; Totey S
J Tissue Eng Regen Med; 2009 Mar; 3(3):163-74. PubMed ID: 19229888
[TBL] [Abstract][Full Text] [Related]
23. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue.
Rebelatto CK; Aguiar AM; Moretão MP; Senegaglia AC; Hansen P; Barchiki F; Oliveira J; Martins J; Kuligovski C; Mansur F; Christofis A; Amaral VF; Brofman PS; Goldenberg S; Nakao LS; Correa A
Exp Biol Med (Maywood); 2008 Jul; 233(7):901-13. PubMed ID: 18445775
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells.
Hung SP; Ho JH; Shih YR; Lo T; Lee OK
J Orthop Res; 2012 Feb; 30(2):260-6. PubMed ID: 21809383
[TBL] [Abstract][Full Text] [Related]
25. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.
Kume S; Kato S; Yamagishi S; Inagaki Y; Ueda S; Arima N; Okawa T; Kojiro M; Nagata K
J Bone Miner Res; 2005 Sep; 20(9):1647-58. PubMed ID: 16059636
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia preconditioned human adipose derived mesenchymal stem cells enhance angiogenic potential via secretion of increased VEGF and bFGF.
Liu L; Gao J; Yuan Y; Chang Q; Liao Y; Lu F
Cell Biol Int; 2013 Jun; 37(6):551-60. PubMed ID: 23505143
[TBL] [Abstract][Full Text] [Related]
27. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
Pérez-Ilzarbe M; Díez-Campelo M; Aranda P; Tabera S; Lopez T; del Cañizo C; Merino J; Moreno C; Andreu EJ; Prósper F; Pérez-Simón JA
Transfusion; 2009 Sep; 49(9):1901-10. PubMed ID: 19497059
[TBL] [Abstract][Full Text] [Related]
28. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
[TBL] [Abstract][Full Text] [Related]
29. [Experimental research on repair of rabbit articular cartilage deffects with composite of autologous cell-carriers].
Bai T; Shu J; Wang J; Lu J; Li W; Pu B
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):487-91. PubMed ID: 18575455
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture.
Vacanti V; Kong E; Suzuki G; Sato K; Canty JM; Lee T
J Cell Physiol; 2005 Nov; 205(2):194-201. PubMed ID: 15880640
[TBL] [Abstract][Full Text] [Related]
31. Culture and neural differentiation of rat bone marrow mesenchymal stem cells in vitro.
Lei Z; Yongda L; Jun M; Yingyu S; Shaoju Z; Xinwen Z; Mingxue Z
Cell Biol Int; 2007 Sep; 31(9):916-23. PubMed ID: 17482842
[TBL] [Abstract][Full Text] [Related]
32. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
[TBL] [Abstract][Full Text] [Related]
33. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia.
Hoffmann J; Glassford AJ; Doyle TC; Robbins RC; Schrepfer S; Pelletier MP
Thorac Cardiovasc Surg; 2010 Apr; 58(3):136-42. PubMed ID: 20379963
[TBL] [Abstract][Full Text] [Related]
34. Influence of mesenchymal stem cells derived from bone marrow of children with oncohematological diseases on proliferation and self-renewal of hematopoietic progenitor cells in vitro.
Isaikina Y; Shman T
Exp Oncol; 2008 Jun; 30(2):121-8. PubMed ID: 18566575
[TBL] [Abstract][Full Text] [Related]
35. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR; Volloch V; Kaplan DL
Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
[TBL] [Abstract][Full Text] [Related]
36. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro.
Sun Y; Chen L; Hou XG; Hou WK; Dong JJ; Sun L; Tang KX; Wang B; Song J; Li H; Wang KX
Chin Med J (Engl); 2007 May; 120(9):771-6. PubMed ID: 17531117
[TBL] [Abstract][Full Text] [Related]
38. Effect of negative pressure on human bone marrow mesenchymal stem cells in vitro.
Zhang YG; Yang Z; Zhang H; Wang C; Liu M; Guo X; Xu P
Connect Tissue Res; 2010; 51(1):14-21. PubMed ID: 20067412
[TBL] [Abstract][Full Text] [Related]
39. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
40. Biological characterization of CD34+ cells mobilized into peripheral blood.
Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
